This whole situation reminds me of the numerous instances in the last year where Chinese companies listed on U.S. stock exchanges were accused of fraud and eventually de-listed from the exchanges.
Roughly 2-3 years ago Chinese companies started popping up on U.S. exchanges with fantastic growth stores and potential. As it turns out, some of the information was falsified by the companies to attract investment $. Many of the companies went to great lengths to perpetuate their fraudulent activity. Going off of memory - Longtop Financial for example, went so far as to collude with its bank and had forged bank statements created which it used to falsify it's cash position.
In hindsight, for a majority of the cases, it seems preposterous that anyone involved in the fraud would have actually expected the charade to work for more than a few months. Yet even after the spotlight was shown on many of these companies they vehemently denied any wrongdoing.
This reminds me of Amphastar, which came from virtually no where when it gained approval for its generic Lovenox. And is now making one abnormal statement after another. I don't think we can trust that anything Amphastar says is even close to 100% truth.
Market Data 
Markets 
AI
